Clinical Trial Update: Adjuvant Intensification for LAR [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating adjuvant intensification for LAR in breast cancer, including triple-negative breast cancer. The study status is not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer Females, Triple Negative Breast Cancer (TNBC) | Phase 3 | Status: NOT_YET_RECRUITING